CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on developing a method to detect how cancer drugs bind to target proteins using nanotechnology and advanced mass cytometry. The goal is to improve the selection of effective therapies for patients by profiling drug-target interactions in a single experiment.
Cancer is the second highest cause of death in Europe and one of the biggest challenges facing humanity.
The discovery of multi-kinase inhibitors has emerged as a strong alternative treatment for many cancers.
However, the appearance of severe side effects due to their intrinsic target promiscuity limits the dosage and efficiency of these treatments.
Therefore the characterisation of this promiscuity is crucial to develop selective and safe treatments.
We propose a versatile and efficient approa…
UNIVERSIDAD DE GRANADA
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
